default author photo

Stéphane Hominal

Centre Hospitalier Pierre Bénite

SCHOLARLY PAPERS

1

DOWNLOADS

71

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Real-World Efficacy and Safety of Combination Nivolumab Plus Ipilimumab for Untreated, Unresectable, Pleural Mesothelioma: The Meso-Immune (Gfpc 04-2021) Trial

Number of pages: 27 Posted: 02 Feb 2024
affiliation not provided to SSRN, Normandie Université, University of Lille, PSL Research University - Institut Curie, University of Claude Bernard Lyon 1 - Centre Léon Bérard, Lyon Sud Hospital - Civils Hospices of Lyon, Institut d'Administration des Entreprises d'Aix-en-Provence (IAE Aix), Centre Hospitalier Pierre Bénite, Clinique Ambroise Paré, University of Strasbourg, Groupe Hospitalier du Havre, Centre Hospitalier Henri Duffaut, University of Caen Normandie - Centre Hospitalier - CHU de Caen, Université de Nantes, University of Bordeaux - CHU de Bordeaux, University of Angers - CHU Angers, CHITS Sainte Musse, Université Lyon 1, Centre Hospitalier Intercommunal de Créteil and Aix-Marseille University
Downloads 71 (875,328)

Abstract:

Loading...

pleural mesothelioma, Immunotherapy, real-world data, survival, safety